Several studies suggest that
rifampicin more than doubles the clearance of zidovudine. In some subjects increased haematological
toxicity was also seen.
Rifampicin is predicted to interact similarly with abacavir.
Be alert for any evidence of a reduced response to these antivirals and monitor for haematological
toxicity.